Financials
- Market Capitalization 41.09 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-13.39
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 214 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 756.01 USD | -0.89% | +2.20% | -4.18% | +35.75% | 77.84 B USD | ||
| 313 | ARGX argenx SE - American Depositary Shares | 800.84 USD | -1.41% | -14.01% | -20.28% | +0.26% | 49.56 B USD | ||
| 448 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 222.88 USD | -1.82% | -1.07% | -10.91% | -51.77% | 29.82 B USD | ||
| 492 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.84 USD | -1.63% | +0.25% | -3.10% | +52.55% | 25.38 B USD |